11L Stock Overview Engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Canopy Growth Corporation Competitors Price History & Performance
Summary of share price highs, lows and changes for Canopy Growth Historical stock prices Current Share Price CA$1.95 52 Week High CA$13.82 52 Week Low CA$1.81 Beta 1.71 1 Month Change -23.68% 3 Month Change -49.42% 1 Year Change -47.30% 3 Year Change -97.59% 5 Year Change -99.05% Change since IPO -92.00%
Recent News & Updates
Canopy Growth Corporation to Report Q3, 2025 Results on Feb 07, 2025 Jan 24
Canopy Growth Corporation Launches Two Holiday-Inspired Cannabis Products from Tweed, Including A Sugar-Free Cranberry Ginger Ale and Tweed Snowtorious 91K Flower Dec 05 Canopy Growth Corporation Appoints Luc Mongeau as Chief Executive Officer, Effective January 6, 2025
Canopy Growth Launches Claybourne Infused Pre-Rolls in Canada Nov 21
New major risk - Financial position Nov 10
Second quarter 2025 earnings released: CA$1.52 loss per share (vs CA$1.86 loss in 2Q 2024) Nov 10 See more updates
Canopy Growth Corporation to Report Q3, 2025 Results on Feb 07, 2025 Jan 24
Canopy Growth Corporation Launches Two Holiday-Inspired Cannabis Products from Tweed, Including A Sugar-Free Cranberry Ginger Ale and Tweed Snowtorious 91K Flower Dec 05 Canopy Growth Corporation Appoints Luc Mongeau as Chief Executive Officer, Effective January 6, 2025
Canopy Growth Launches Claybourne Infused Pre-Rolls in Canada Nov 21
New major risk - Financial position Nov 10
Second quarter 2025 earnings released: CA$1.52 loss per share (vs CA$1.86 loss in 2Q 2024) Nov 10
Insider recently sold €93k worth of stock Aug 27
David Klein Announces to Retire as CEO of Canopy Growth Corporation Aug 16
First quarter 2025 earnings released: CA$1.63 loss per share (vs CA$0.12 loss in 1Q 2024) Aug 11
Canopy Growth Corporation to Report Q2, 2025 Results on Nov 12, 2024 Aug 06
Canopy Growth Corporation to Report Q1, 2025 Results on Aug 09, 2024 Jul 26
Canopy Growth Corporation, Annual General Meeting, Sep 24, 2024 Jul 09 Canopy Growth Corporation has filed a Follow-on Equity Offering in the amount of $250 million. Jun 08
Full year 2024 earnings released: CA$6.22 loss per share (vs CA$70.69 loss in FY 2023) Jun 04
Canopy Growth Corporation to Report Q4, 2024 Results on May 30, 2024 May 18
New major risk - Shareholder dilution May 18 Canopy Growth Corporation (TSX:WEED) exercised its option to acquire Wana Brands for $300 million. May 08
Less than half of directors are independent Apr 22
Canopy Growth Corporation Announces Board and Committee Changes Apr 20 Canopy Growth Launches New Pre-Rolls from 7Acres and Hiway Feb 22
Third quarter 2024 earnings released: CA$2.78 loss per share (vs CA$4.57 loss in 3Q 2023) Feb 11
Canopy Growth Corporation Announces Board Changes Feb 10
New major risk - Revenue and earnings growth Feb 10
Bioriginal Food & Science Corporation acquired KeyLeaf Life Sciences from Canopy Growth Corporation (TSX:WEED). Feb 08
Canopy Growth Corporation Announces the Introduction of New Product Offerings Across the Company's Adult Use and Medical Cannabis Portfolio Jan 24 Canopy Growth Corporation announced that it expects to receive $35.000008 million in funding Jan 18
Canopy Growth Corporation to Report Q3, 2024 Results on Feb 09, 2024 Jan 13 Canopy Growth Corporation announced that it expects to receive $30 million in funding Jan 09
Inspirit Management Ltd acquired This Works Products Limited from Canopy Growth Corporation (TSX:WEED) for £9.3 million. Dec 19
Canopy Growth Corporation Partners with Marquee Brands Partners and Martha Stewart CBD to Unveil New Line of Need-Based CBD Gummies Nov 30
New minor risk - Insider selling Nov 24
Canopy Growth Corporation Announces the Addition of Four New Flower Product Offerings from Iconic Brands 7ACRES and Tweed Nov 17
New major risk - Financial position Nov 13
New minor risk - Financial position Nov 10
Second quarter 2024 earnings released: CA$0.19 loss per share (vs CA$0.47 loss in 2Q 2023) Nov 10
Insufficient new directors Oct 01 Canopy Growth Corporation announced that it expects to receive $24.99312 million in funding Sep 20
Canopy Growth Corporation announced that it expects to receive $24.99312 million in funding Sep 19
Canopy Growth Corporation Announces Addition of Five New Pre-Roll Flower Product Offerings from Iconic Brands Tweed, 7ACRES, and for the First Time, from Spectrum Therapeutics Aug 23 Canopy Growth Corporation Announces Executive Changes
Canopy Growth Receives Written Notice from Nasdaq Regarding Minimum Bid Price Requirement Jul 15
Canopy Growth Corporation, Annual General Meeting, Sep 25, 2023 Jul 08
Lieff Cabraser Heimann & Bernstein, LLP Announces Class Action Lawsuit on Behalf of the Investors in Canopy Growth Corporation Who Suffered Losses from Purchasing or Otherwise Acquiring Canopy Securities Between June 1, 2021 and May 10, 2023 Jul 06
An unknown buyer acquired a Facility in Modesto, CA from Canopy Growth Corporation (TSX:WEED). Jun 30
Canopy Growth Corporation to Report Q4, 2023 Results on Jun 22, 2023 Jun 22
Canopy Growth Corporation announced delayed amended 10-K filing Jun 15
Canopy Growth Corporation announced delayed annual 10-K filing May 28
Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Canopy Growth Corporation May 24
Third quarter 2023 earnings released: CA$0.54 loss per share (vs CA$0.28 loss in 3Q 2022) Feb 10 420 Investments Ltd. acquired Five Retail Locations in Alberta from Canopy Growth Corporation (TSX:WEED). Canopy Growth Corporation Announces Termination of Julious Grant as Chief Commercial Officer, Effective December 16, 2022 Dec 03
Second quarter 2023 earnings released: CA$0.47 loss per share (vs CA$0.028 loss in 2Q 2022) Nov 10
Canopy Growth Corporation (TSX:WEED) acquired Manufacturing facility in USA. Nov 10
Canopy Growth Corporation Announces Extension of Its Ace Valley Brand Portfolio with the Launch of Lust Cherry Rose and Thrust Watermelon Goji Oct 22 420 Investments Ltd. agreed to acquire Five Retail Locations in Alberta from Canopy Growth Corporation (TSX:WEED).
Limited-Edition Pumpkin Spice CBD Wellness Gummies™ Arrive Just in Time for Fall As Martha Stewart CBD Expands Portfolio Aug 16
Canopy Growth Corporation Appoints Christelle Gedeon as Chief Legal Officer Aug 03
Canopy Growth Corporation Announces New Premium Flower Line-Up Jul 29
Canopy Growth Corporation Celebrates Summer with New 'Just Hits Different' Beverage Campaign Jul 01
Canopy Growth Corporation to Report Q3, 2023 Results on Feb 09, 2023 Jun 25 Canopy Growth Corporation to Report Q2, 2023 Results on Nov 09, 2022
Canopy Growth Corporation, Annual General Meeting, Sep 15, 2022 Jun 23
Canopy Growth Corporation unveils Line-Up of New Offerings Across Its Premium Brand Portfolio – 7ACRES, Ace Valley, Deep Space and Doja May 21
Canopy Growth Corporation Provides Non-Cash Impairment Charges Guidance for the Fourth Quarter of 2022 Apr 27
Canopy Growth Corporation to Report Q4, 2022 Results on May 27, 2022 Apr 08 Canopy Growth Unveils Behind the Scenes Look at 7Acres' Premium Flower Production Apr 07
Canopy Growth Corporation Appoints Judy Hong as Chief Financial Officer
Dermapharm Holding SE (XTRA:DMP) completed the acquisition of C³ - Cannabinoid Compound Company Gmbh from Canopy Growth Corporation (TSX:WEED). Feb 02
Dermapharm Holding SE (XTRA:DMP) completed the acquisition of C³ - Cannabinoid Compound Company Gmbh from Canopy Growth Corporation (TSX:WEED). Feb 01 Shareholder Returns 11L DE Pharmaceuticals DE Market 7D -2.0% -3.9% -0.02% 1Y -47.3% -12.4% 15.1%
See full shareholder returns
Return vs Market: 11L underperformed the German Market which returned 15.1% over the past year.
Price Volatility Is 11L's price volatile compared to industry and market? 11L volatility 11L Average Weekly Movement 13.7% Pharmaceuticals Industry Average Movement 5.2% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.3% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: 11L's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 11L's weekly volatility has decreased from 21% to 14% over the past year, but is still higher than 75% of German stocks.
About the Company Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices.
Show more Canopy Growth Corporation Fundamentals Summary How do Canopy Growth's earnings and revenue compare to its market cap? 11L fundamental statistics Market cap €239.81m Earnings (TTM ) -€323.60m Revenue (TTM ) €187.63m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 11L income statement (TTM ) Revenue CA$276.75m Cost of Revenue CA$192.61m Gross Profit CA$84.14m Other Expenses CA$561.45m Earnings -CA$477.31m
Last Reported Earnings
Dec 31, 2024
Earnings per share (EPS) -3.90 Gross Margin 30.40% Net Profit Margin -172.47% Debt/Equity Ratio 74.7%
How did 11L perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/02/08 14:32 End of Day Share Price 2025/02/07 00:00 Earnings 2024/12/31 Annual Earnings 2024/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github .
Analyst Sources Canopy Growth Corporation is covered by 28 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Aaron Grey Alliance Global Partners Frederico Yokota Choucair Gomes ATB Capital Markets Gaurav Jain Barclays
Show 25 more analysts 
